We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00221559
First Posted: September 22, 2005
Last Update Posted: May 9, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Scientific research fund Bruges
Information provided by:
University Hospital, Ghent
September 12, 2005
September 22, 2005
May 9, 2006
September 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00221559 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group
Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group
Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Cystic Fibrosis
Procedure: Blood sampling for determination of serum Zn
Not Provided
Van Biervliet S, Van Biervliet JP, Robberecht E. Serum zinc in patients with cystic fibrosis at diagnosis and after one year of therapy. Biol Trace Elem Res. 2006 Sep;112(3):205-11.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
0
Not Provided
Not Provided

Inclusion Criteria:

  • Diagnosis of cystic fibrosis

Exclusion Criteria:

Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Belgium
 
 
NCT00221559
UZGhent 001
Not Provided
Not Provided
Not Provided
Not Provided
University Hospital, Ghent
Scientific research fund Bruges
Principal Investigator: Stephanie Van Biervliet, MD University Hospital, Ghent
University Hospital, Ghent
May 2006